You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
科大訊飛(002230.SZ):擬將控股子公司訊飛醫療分拆至香港聯交所主板上市
格隆匯 01-09 20:13

格隆匯1月9日丨科大訊飛(002230.SZ)公佈關於分拆所屬子公司訊飛醫療科技股份有限公司至香港聯交所上市的預案,公司擬將控股子公司訊飛醫療分拆至香港聯交所主板上市。本次分拆完成後,科大訊飛仍將維持對訊飛醫療的控制權。

本次分拆上市完成後,訊飛醫療將通過香港資本市場獲得融資,有助於訊飛醫療繼續保持醫療人工智能領域的領先地位,並提高其國際影響力,進而增強上市公司的綜合競爭力。

訊飛醫療本次發行的初始發行規模為不超過緊接發行後經擴大後總股本的15%超額配售權行使前),即不超過2,008.99萬股,並授予全球協調人/簿記管理人不超過上述H股初始發行規模15%的超額配售權,即在全額行使超額配售權的情況下,訊飛醫療本次發行的H股股份數擬不超過2,310.34萬股。

上市公司及其下屬子公司(除擬分拆主體及資產外)與訊飛醫療在主營業務、應用場景市場範圍、客户羣體等方面均存在顯著差異,同時訊飛醫療與上市公司及下屬子公司(除擬分拆主體及資產外)保持相對較高的獨立性,本次分拆不會對上市公司持續經營構成實質性影響。

本次分拆上市後,訊飛醫療將擁有獨立融資平台並藉此深耕主營業務,有利於增強訊飛醫療在醫療行業進行技術儲備及市場開拓的能力,通過提升市場綜合競爭力而提升公司未來整體盈利水平。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account